Copper related toxic effects on cellular protein metabolism in human astrocytes

BioFactors

Volumn 24, Issue 1-4, 2005, Pages 255-261

  Merker, Katrin ^a   Hapke, Doreen ^a   Reckzeh, Kristian ^a   Schmidt, Hartmut ^a   Lochs, Herbert ^a   Grune, Tilman ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Astrocytes; Copper induced oxidation; Oxidative stress; Wilson disease

Indexed keywords

CARBONYL DERIVATIVE; CELL PROTEIN; COPPER; CUPRIC CHLORIDE; ENZYME; GLYCERINALDEHYD 3 PHOSPHAT DEHYDROGENASE; HYDROGEN PEROXIDE; OXIDIZING AGENT; PROTEIN DERIVATIVE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CELL GROWTH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; COPPER METABOLISM; CYTOTOXICITY; GLIA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN METABOLISM; WILSON DISEASE;

EID: 28644438974     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520240130     Document Type: Article

References (26)

1. L. Agullo, A. Garcia and J. Hidalgo, Metallothionein-I+II induction by zinc and copper in primary cultures of rat microglia, Neurochem. Int. 33 (1998), 237-242.
2. M. Arredondo, V. Cambiazo, L. Tapia, M. Gonzalez-Aguero, M.T. Nunez, R. Uauy and M. Gonzalez, Copper overload affects copper and iron metabolism in Hep-G2 cells, Am. J. Physiol. (Gastrointest. Liver Physiol.) 287 (2004), G27-G32.
3. M.J. Bingham, T.-J. Ong, K.H. Summer, R.B. Middleton and H.J. McArdle, Physiologic function of the Wilson disease gene product, ATP7B1-3, Am. J. Clin. Nutr. 67 (1998), 982S-987S.
4. I. Bremner, Manifestations of copper excess, Am. J. Clin. Nutr. 67 (1998), 1069S-1073S.
5. G.J. Brewer, Copper Control as an Antiangioganic Anticancer Therapy: Lessons from Treating Wilson's Disease, Exp. Biol. Med. 226 (2001), 665-673.
6. H. Buss, T.P. Chan, K.B. Sluis, N.M. Domigan and C.C. Winterbourn, Protein carbonyl measurement by a sensitive ELISA method, Free Radic. Biol. Med. 23 (1997), 361-366.
7. J. Camakaris, I. Voskobinik and J.F.Mercer, Breakthroughs and Views: Molecular Mechanisms of Copper Homeostasis, Biochem. Biopys. Res. Commun. 261 (1999), 225-232.
8. M.G. Cherian and M.D. Apostolova, Nuclear localization of metallothionein during cell proliferation and differentiation, Cell. Mol. Biol. (Noisy-le-grand) 46 (2000), 347-356.
9. D. Fu, T.J. Beeler and T.M. Dunn, Sequence, mapping and disruption of CCC2, a gene that cross-complements the Ca(2+)-sensitive phenotype of csgl mutants and encodes a P-type ATPase belonging to the Cu(2+)-ATPase subfamily, Yeast 11 (1995), 283-292.
10. T. Gasull, M. Giralt, J. Hernandez, P. Martinez, I. Bremner and J. Hidalgo, Regulation of metallothionein concentrations in rat brain: Effect of glucocorticoids, zinc, copper, and endotoxin, Am. J. Physiol. 266 (1994), E760-E767.
11. T. Grune, T. Reinheckel and K.J. Davies, Degradation of oxidized proteins in mammalian cells, FASEB J. 11 (1997), 526-534.
12. T. Grune, T. Reinheckel, M. Joshi and K.J. Davies, Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome, J. Biol. Chem. 270 (1995), 2344-2351.
13. J. Hidalgo, A. Garcia, A.M. Oliva, M. Giralt, T. Gasull, B. Gonzalez, H. Milnerowicz, A. Wood and I. Bremner, Effect of zinc, copper and glucocorticoids on metallothionein levels of cultured neurons and astrocytes from rat brain, Chem. Biol. Interact. 93 (1994), 197-219.
14. T. Hoshino, K. Kumasaka, K. Kawano, F. Yamagishi, I. Koyama, Y. Fujimori-Arai, T. Nakajima and T. Komoda, Low serum alkaline phosphatase activity associated with severe Wilson's disease. Is the breakdown of alkaline phosphatase molecules caused by reactive oxygen species? Clin. Chim. Acta 238 (1995), 91-100.
15. M.C. Linder, L. Wooten, P. Cerveza, S. Cotton, R. Shulze and N. Lomeli, Copper transport, Am. J. Clin. Nutr. 67 (1998), 965S-971S.
16. J.M. McCord, Superoxide Dismutase in Aging and Disease: An Overview, Meth. Enzym. 349 (2002), 331-341.
17. J.F.B. Mercer, The molecular basis of copper-transport diseases, TRENDS in Molecular Medicine 7(2) (2001), 64-69.
18. K. Merker, N. Sitte and T. Grune, Hydrogen peroxide-mediated protein oxidation in young and old human MRC-5 fibroblasts, Arch. Biochem. Biophys. 375 (2000), 50-54.
19. O. Niemelä, S. Parkkila, B. Bradford, Y. Iimuro, M. Pasanen, and R.G. Thurman, Effect of Kupffer Cell Inactivation on Ethanol-Induced Protein Adducts in the Liver, Free Radic. Biol. Med. 33 (2002), 350-355.
20. R. Seth, S. Yang, S. Choi, M. Sabean and E.A. Roberts, In vitro assessment of copper-induced toxicity in the human hepatoma line, HepG2, Toxicol. In Vitro 18 (2004), 501-509.
21. N. Sitte, K. Merker and T. Grune, Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts, FEBS Lett. 440 (1998), 399-402.
22. R.J. Sokol, M.W. Devereaux, K. O'Brien, R.A. Khandwala and J.P. Loehr, Abnormal hepatic mitochondrial respiration and cytochrome C oxidase activity in rats with long-term copper overload, Gastroenterology 105 (1993), 178-187.
23. M. Solioz, A. Odermatt and R. Krapf, Copper pumping ATPases: Common concepts in bacteria and man, FEBS Lett. 346 (1994), 44-47.
24. M. Suzuki and J.D. Gitlin, Intracellular localization of the Menkes and Wilson's disease proteins and their role in intracellular copper transport, Ped. Internat. 41 (1999), 436-442.
25. R. Wapnir, Copper absorption and bioavailability, Am. J. Clin. Nutr. 67 (1998), 1054S-1060S.
26. N.T. Watt and N.M. Hooper, The response of neurones and glial cells to elevated copper, Brain Res. Bull. 55 (2001), 219-224.